References
- Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113(4):481-517. https://doi.org/10.1038/ajg.2018.27
- Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, et al. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol. 2018.
- Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14(2):111-9. https://doi.org/10.5217/ir.2016.14.2.111
- Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, et al. Second Korean Guidelines for the Management of Crohn's Disease. Korean J Gastroenterol. 2017;69(1):29-54. https://doi.org/10.4166/kjg.2017.69.1.29
- Wehkamp J, Gotz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int. 2016;113(5):72-82.
- Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS. Infliximab in inflammatory bowel disease. Ther Adv Chronic Dis. 2019;10:2040622319838443. https://doi.org/10.1177/2040622319838443
- Choi CW, Son CG, Cho CK. The oriental-western literal study of Crohn's disease. Journal of Daejeon University Research Institute of Korean Medicine. 2001;9(2):251-68.
- Lee MS, Hwang MW, Kim YH. A Case Study of a Soyangin Patient with Crohn's Disease who Reported Symptomatic Improvement after Being Treated with Dojeokgangki-tang. Journal of Sasang Constitutional Medicine. 2012;24(2):61-70. https://doi.org/10.7730/JSCM.2012.24.2.061
- Na WG, Yang MR, Lee HJ, Park EJ. A case report of Crohn's disease. Journal of Korean Oriental Pediatrics. 2002;16(2):51-8.
- Kim SW, Lee OJ, Shin JC. A Case Study of a Crohn's Disease Patient Treated with Oriental Medical Treatment. Korean J Acupunct. 2014;31(4):247-52. https://doi.org/10.14406/acu.2014.035
- Seo SH, Jeong JO, Lee EJ, Choi IS, Park SE, Kim WI, et al. A Case Study of Suspected Crohn's Disease Treated with Bojanggunbitang. The Journal of Internal Korean Medicine. 2004;25(3):648-54.
- Park JM, Kim HJ, Keum DH, Park YH, Lee MJ. The effect of Oriental Medical Treatment on Crohn's disease; 1 Case Report. The Journal of Chuna Manual Medicine for Spine & Nerves. 2010;5(1):57-66.
- Lee BH, Won JY, Park JR, Lee HS. Remissions of Crohn's Disease at Onset and Relapse Using Herbal Medicine: A Case Report. Korean J Acupunct. 2020;37(3):183-90. https://doi.org/10.14406/acu.2020.019
- Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006;6:19. https://doi.org/10.1186/1472-6882-6-19
- Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):655-62. https://doi.org/10.1002/ibd.21360
- Abitbol V, Lahmek P, Buisson A, Olympie A, Poupardin C, Chaussade S, et al. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey. Eur J Gastroenterol Hepatol. 2014;26(3):288-94. https://doi.org/10.1097/MEG.0000000000000040
- Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-44. https://doi.org/10.1016/s0016-5085(76)80163-1
- Todo Y, Kim JO. Yakjing 1st ed. Kyonggi-do: Mulgogisoop; 2014.
- Park JH KH, Seo BI. A philological study on poisoning of Ephedrae Herba. The Journal of Ease-West Medicine. 2012.
- Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Manag Care. 2004;10(8):544-52.
- Knyazev OV, Kagramanova AV, Korneeva IA, Noskova KK, Belousov SV, Parfenov AI. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases. Ter Arkh. 2019;91(4):53-61.
- Horiba Y, Yoshino T, Watanabe K. Kampo Extract of Shinbuto Improved Refractory Diarrhea in Milroy's Disease. Glob Adv Health Med. 2013;2(1):14-7. https://doi.org/10.7453/gahmj.2013.2.1.003
- Won JY, Lee BH, Jung WM, Chae YB, Lee HS. Herbal medicine for inflammatory bowel diseases: development of pattern identification algorithms by retrospective analysis of case series data. Eur J Integr Med. 2020;36:101114. https://doi.org/10.1016/j.eujim.2020.101114
- Lee JG YC. The study on chemical components and Korean medical effects of Poria cocos. The Journal of Jeahan Oriental Medical Academy. 2015.
- Liu X, Yu X, Xu X, Zhang X, Zhang X. The protective effects of Poria cocos-derived polysaccharide CMP33 against IBD in mice and its molecular mechanism. Food Funct. 2018;9(11):5936-49. https://doi.org/10.1039/C8FO01604F
- Han KH, Park JM, Jeong M, Han YM, Go EJ, Park J, et al. Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse. Gut Liver. 2017;11(5):655-66. https://doi.org/10.5009/gnl16496
- Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452. https://doi.org/10.1016/j.pharmthera.2019.107452
- Yoo CK, Kwon KR. The Bibilographic studies on Aconiti Ciliare Tuber and Radix Aconiti. J Pharmacopunct. 2001;4(2):87-93. https://doi.org/10.3831/KPI.2001.4.2.087
- Wang X, Wang G, Shang J, Pan H, Zhang XA, Zhou F. Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis. J Int Med Res. 2019;47(8):3534-49. https://doi.org/10.1177/0300060519864800